Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Cloudmed Launches 340B Audit Resource Center


The Health Resources and Services Administration (HRSA) is on pace again this year to conduct about 200 audits of covered entities in the 340B Drug Pricing Program. And once again this year, it appears that more than 60 percent of audits will return with findings. 340B audits with findings can result in serious financial sanctions including repayment to manufacturers, termination of ineligible contract pharmacies and outpatient facilities from the program, or complete program exclusion.


HRSA-AuditResult-Post-Image.jpg



The Health Resources and Services Administration (HRSA) is on pace again this year to conduct about 200 audits of covered entities in the 340B Drug Pricing Program. And once again this year, it appears that more than 60 percent of audits will return with findings. 340B audits with findings can result in serious financial sanctions including repayment to manufacturers, termination of ineligible contract pharmacies and outpatient facilities from the program, or complete program exclusion.


HRSA audit results

While the total number of HRSA audits and sanctions has been consistent for the past few years, there has been a noticeable uptick in OPA (Office of Pharmacy Affairs) audit findings. There’s good reason that being prepared for a HRSA audit is a program requirement, since eventually every covered entity will undergo one. With millions of dollars in prescription drug discounts that can fund more healthcare services at stake, failure to comply is simply not an option.


Proven to produce more savings without more risk

To date, all Cloudmed 340B Recovery clients that have undergone HRSA audits have completed them with no findings. This record of accomplishment is only possible because of our compliance-first approach to 340B ineligible claim and referral capture. Documenting ownership of patient care and prescriptions from outside referrals is essential. Having a clear definition of patient ownership in written policies can prevent considerable back-end justification when the time comes to defend your rationale for 340B drug discount claims. And of course, a bad audit can mean reimbursing drug companies for inappropriate discount claims or exclusion from the program. The Cloudmed 340B team knows what it takes to optimize program savings while minimizing compliance and audit risk, and we are committed to helping covered entities do just that.


“The benefit that we’ve realized through Cloudmed has been fantastic because we would not have been able to realize it in any other way through our retail pharmacy stores,” stated Corrine Hill, Chief Administrative and Compliance Officer at Thundermist Health Center. “There are so many prescriptions that we could not realize written by referral providers. On top of that, some of the value of the drugs has been surprisingly high.”... 


Read the full blog, here.


Today's Posts
Subscribe

This post is related to:

340B